Cargando…
Surveillance for Hepatocellular Carcinoma in Patients with NASH
European and American guidelines recommend surveillance for hepatocellular carcinoma (HCC) by performing ultrasonography on a six-month basis on an at risk population, defined by presence of cirrhosis. HCC, due to non-alcoholic steatohepatitis (NASH), is rising. Patients with NASH have a high risk o...
Autores principales: | Kolly, Philippe, Dufour, Jean-François |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931417/ https://www.ncbi.nlm.nih.gov/pubmed/27338480 http://dx.doi.org/10.3390/diagnostics6020022 |
Ejemplares similares
-
Cell Autophagy in NASH and NASH-Related Hepatocellular Carcinoma
por: Udoh, Utibe-Abasi S., et al.
Publicado: (2022) -
NASH and Hepatocellular Carcinoma: Immunology and Immunotherapy
por: Pinter, Matthias, et al.
Publicado: (2023) -
Modeling NASH and NASH-Induced Hepatocellular Carcinoma: Faster and Better
por: Hirsova, Petra
Publicado: (2021) -
Molecular Pathogenesis of Nonalcoholic Steatohepatitis- (NASH-) Related Hepatocellular Carcinoma
por: Kutlu, Ozlem, et al.
Publicado: (2018) -
NASH, Fibrosis and Hepatocellular Carcinoma: Lipid Synthesis and Glutamine/Acetate Signaling
por: Sunami, Yoshiaki
Publicado: (2020)